Polychlorinated biphenyl exposures differentially regulate hepatic metabolism and pancreatic function: Implications for nonalcoholic steatohepatitis and diabetes.


Journal

Toxicology and applied pharmacology
ISSN: 1096-0333
Titre abrégé: Toxicol Appl Pharmacol
Pays: United States
ID NLM: 0416575

Informations de publication

Date de publication:
15 01 2019
Historique:
received: 16 05 2018
revised: 25 09 2018
accepted: 08 10 2018
pubmed: 13 10 2018
medline: 19 7 2019
entrez: 13 10 2018
Statut: ppublish

Résumé

The endocrine disrupting chemicals, polychlorinated biphenyls (PCBs), have been associated with nonalcoholic steatohepatitis (NASH) and diabetes. However, an integrative analysis of the effects of PCBs on the liver and pancreas has never been performed for the two major PCB subtypes, dioxin-like (DL) and nondioxin-like (NDL), and a mixture of NDL/DL PCBs. Therefore, male C57BL/6 J mice fed a control synthetic diet were treated with either a NDL PCB mixture, Aroclor 1260 (20 mg/kg); a single DL PCB congener, PCB 126 (20 μg/kg); a NDL/DL mixture, Aroclor 1260 plus PCB 126; or vehicle control for 2 weeks. PCB126 had the greatest impact on hepatic lipid metabolism. It caused steatosis due to increased hepatic lipid import with associated hypolipidemia. However, all PCB exposures impacted expression of hepatic lipid metabolism genes in different manners. The 'NASH gene', Pnpla3, was elevated by Aroclor 1260, but decreased by all other exposures. The expression of hepatokines implicated in metabolic syndrome (Fgf21, Igf1, and betatrophin) were differentially regulated. The NDL/DL PCB mixture had the greatest effects on pancreatic histology, including acinar cell atrophy, mild steatosis, and fibrosis without ductal changes or immune cell infiltration. It decreased expression of insulin and altered the expression of genes regulating islet identity. None of these exposures was associated with altered HOMA-IR or HOMA-B. In summary, PCB exposures differentially regulated liver and pancreas structure and function. Novel mechanisms for PCB-induced endocrine/metabolic disruption included altered hepatokines and Pnpla3 as well as 'PCB pancreatopathy' that was associated with altered expression of pancreatic islet identity factors. More research is required to understand fully these findings in the context of human NASH and diabetes.

Identifiants

pubmed: 30312631
pii: S0041-008X(18)30469-1
doi: 10.1016/j.taap.2018.10.011
pmc: PMC7059560
mid: NIHMS1010404
pii:
doi:

Substances chimiques

Aroclors 0
Endocrine Disruptors 0
aroclor 1260 11096-82-5
Polychlorinated Biphenyls DFC2HB4I0K
PNPLA3 protein, mouse EC 3.1.1.3
Phospholipases A2, Calcium-Independent EC 3.1.1.4
3,4,5,3',4'-pentachlorobiphenyl TSH69IA9XF

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

22-33

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM113226
Pays : United States
Organisme : NIAAA NIH HHS
ID : P50 AA024337
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES021375
Pays : United States
Organisme : NIEHS NIH HHS
ID : F31 ES028982
Pays : United States
Organisme : NIEHS NIH HHS
ID : R35 ES028373
Pays : United States
Organisme : NIEHS NIH HHS
ID : P42 ES023716
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Références

J Endocrinol. 2012 Nov;215(2):303-11
pubmed: 22946080
Toxicology. 2015 Dec 2;338:1-7
pubmed: 26410179
Arch Biochem Biophys. 2010 Dec 15;504(2):221-7
pubmed: 20831858
Diabetes. 2009 Jan;58(1):250-9
pubmed: 18840786
J Biol Chem. 2009 Sep 18;284(38):25984-92
pubmed: 19617349
J Diabetes. 2016 Jul;8(4):516-32
pubmed: 26119400
Gastroenterology. 2010 Aug;139(2):653-63
pubmed: 20303349
Gastroenterology. 2010 Aug;139(2):456-63
pubmed: 20451522
Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16109-14
pubmed: 24043787
Can J Biochem Physiol. 1959 Aug;37(8):911-7
pubmed: 13671378
J Toxicol Environ Health A. 2003 Aug 8;66(15):1391-404
pubmed: 12857631
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18831-6
pubmed: 19850873
Proc Natl Acad Sci U S A. 2005 May 17;102(20):7297-302
pubmed: 15883383
Hepatology. 2015 Jan;61(1):108-18
pubmed: 24917523
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Sci Total Environ. 2016 Jan 15;541:1463-1476
pubmed: 26490526
Mol Cell Biol. 2013 May;33(10):2047-55
pubmed: 23508103
Cell. 2013 May 9;153(4):747-58
pubmed: 23623304
Reprod Toxicol. 2017 Mar;68:3-33
pubmed: 27760374
Environ Sci Technol. 2015 Jan 20;49(2):1156-64
pubmed: 25510359
Environ Health Perspect. 2012 May;120(5):727-32
pubmed: 22334129
Toxicol Sci. 2012 Aug;128(2):377-86
pubmed: 22539624
Toxicol Sci. 2018 Apr 1;162(2):622-634
pubmed: 29329451
Regul Toxicol Pharmacol. 2013 Nov;67(2):278-84
pubmed: 23973911
Pancreas. 2016 Sep;45(8):1104-10
pubmed: 26918874
Dig Dis Sci. 2015 Aug;60(8):2529-37
pubmed: 25784075
Environ Toxicol. 2016 Jun;31(6):671-8
pubmed: 25409620
Cell. 2014 Oct 23;159(3):691-6
pubmed: 25417115
Toxicol Sci. 2014 Aug 1;140(2):283-97
pubmed: 24812009
Genomics. 2017 Oct;109(5-6):408-418
pubmed: 28684091
Liver Int. 2016 Nov;36(11):1563-1579
pubmed: 27276701
Toxicol Appl Pharmacol. 2016 Jul 15;303:90-100
pubmed: 27180240
Sci Total Environ. 2002 May 6;290(1-3):181-98
pubmed: 12083709
Environ Health Perspect. 2010 Dec;118(12):1735-42
pubmed: 21126940
Sci Rep. 2016 Jun 13;6:27882
pubmed: 27292372
Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5242-7
pubmed: 24706823
Nat Genet. 2008 Dec;40(12):1461-5
pubmed: 18820647
Toxicol Sci. 2018 Jul 1;164(1):39-49
pubmed: 29684222
Xenobiotica. 2017 Sep;47(9):807-820
pubmed: 27458090
Toxicol Appl Pharmacol. 2014 Sep 15;279(3):380-390
pubmed: 24998970
Nat Rev Cancer. 2014 Dec;14(12):801-14
pubmed: 25568920
Toxicol Sci. 2016 Feb;149(2):396-410
pubmed: 26612838
Hepatology. 2010 Feb;51(2):474-81
pubmed: 19902480
J Clin Invest. 2012 Nov;122(11):4130-44
pubmed: 23023705
Environ Sci Technol. 2015 Aug 18;49(16):10084-92
pubmed: 26190026
Sci Signal. 2013 May 07;6(274):ra31
pubmed: 23652203
Toxicol Pathol. 2013 Feb;41(2):343-60
pubmed: 23262638
Nutr Metab Cardiovasc Dis. 2006 Sep;16(6):e7-8
pubmed: 16935697
Hepatology. 2010 Sep;52(3):904-12
pubmed: 20648472
Nat Rev Endocrinol. 2017 Mar;13(3):129-130
pubmed: 28106150
Hepatology. 2010 Sep;52(3):1134-42
pubmed: 20648554
J Biol Chem. 2016 Jul 15;291(29):15378-87
pubmed: 27226639
J Biol Chem. 2017 Jun 2;292(22):9175-9190
pubmed: 28404815

Auteurs

Hongxue Shi (H)

Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.

Jian Jan (J)

Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.

Josiah E Hardesty (JE)

Department of Biochemistry and Molecular Genetics, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.

K Cameron Falkner (KC)

Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.

Russell A Prough (RA)

Department of Biochemistry and Molecular Genetics, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.

Appakalai N Balamurugan (AN)

Department of Surgery, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.

Sri Prakash Mokshagundam (SP)

Department of Medicine, Division of Endocrinology, Metabolism & Diabetes, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.

Suresh T Chari (ST)

Department of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 55902, United States.

Matthew C Cave (MC)

Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY, 40202, United States; Department of Biochemistry and Molecular Genetics, School of Medicine, University of Louisville, Louisville, KY, 40202, United States; Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, School of Medicine, University of Louisville, Louisville, KY, 40202, United States. Electronic address: matt.cave@louisville.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH